[Erin]

Here is the link to a very clear, informative study out of the Jonsson Cancer Center at UCLA

http://www.cancer.mednet.ucla.edu/ne...item_id=224168

The first part reads:

Survival Increased in Early Stage Breast Cancer After Herceptin-Chemotherapy

Combining the molecularly targeted therapy Herceptin with chemotherapy in women with early stage breast cancer significantly improves disease-free survival for patients with a specific genetic mutation that results in very aggressive disease, a top UCLA researcher reported Thursday.

Dr. Dennis Slamon, whose laboratory and clinical research lead to the development of Herceptin, reported results of the Phase III study of more than 3,200 women Thursday at the 29th annual San Antonio Breast Cancer Symposium.

I believe this is the study that was reported on at the San Antonia conference.

Best of luck!